Magazine Transcript
"Governance Systems Required for Pharmaceutical Companies"

Details

Author
Related Practice Areas Health Care, Pharmaceuticals and Medical Sciences Life Sciences
Language Japanese
Publication Legal mind
No.409
Date of Publication May 21, 2019
Link Japan Pharmaceutical Industry Legal Affairs Association

Health Care, Pharmaceuticals and Medical Sciences:Publications

Book
"MR Textbook 2024"
Magazine Article
"Potential for Industry-Academia-Government Collaboration on Sustainability in the Healthcare Sector"
Book
"Q&A: Legal Affairs in Specific Types of Business - Medical Devices"
Book
"Q&A: Legal Affairs in Specific Types of Business - Pharmaceuticals"
Magazine Article
"Why is "Public Health" Important for Human Resources and Labor Affairs?"

View All

Life Sciences:Publications

"Issues Under Intellectual Property Law and Corporate Handling of Metaverse and Generative AI (Part 2): Patent Act, Trademark Act, Design Act, and Unfair Competition Prevention Act"
Magazine Article
"Issues Under Intellectual Property Law and Corporate Handling of Metaverse and Generative AI (Part 1): Copyright Act"
Magazine Article
"Emergence of Generative AI and Policies Concerning AI Governance in Singapore and Japan - Comparisons with Other Main Territories"
Book
"Positioning of Medical Devices Under the Pharmaceutical Affairs Law and Notes on Development, Approval, and Certification Systems"
Book
”Comprehensive Analysis of M&A Laws of Japan, 2nd edition”

View All

Takamasa Horio:Publications

Book
"MR Textbook 2024"
Book
"Q&A: Legal Affairs in Specific Types of Business - Medical Devices"
Book
"Q&A: Legal Affairs in Specific Types of Business - Pharmaceuticals"
Magazine Article
"Chambers Global Practice Guides Medical Cannabis and Cannabinoid Regulation 2023 - Japan Trends and Developments"
Magazine Article
"Medical Digital Transformation: Latest Trends in Developing Digital Medical Services and Related Knowledge (13) - Legal Considerations Concerning Medical Applications of AI; Discussions about Foundational Matters for Further Development"

View All